XML 40 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Net Loss Per Share
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Numerator:  
Net loss$(160,304)$(102,574)$(659,579)$(263,412)
Denominator:
Weighted average common shares outstanding—basic and diluted
94,372,159 68,320,125 87,936,923 68,258,757 
Net loss per share — basic and diluted$(1.70)$(1.50)$(7.50)$(3.86)
The Company's potential dilutive securities include share options which have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common shareholders of the Company is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:
 As of September 30,
 20242023
Options to purchase common shares13,094,018 9,740,921 
Warrants to purchase common shares294,195 — 
Restricted share units
279,657 — 
 Total13,667,870 9,740,921